低血小板计数,免疫球蛋白耐药性和冠状动脉参与Kawasaki病
Hiroya Masuda1, Jun Matsubayashi2, Ryusuke Ae3
1Division of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. m15099hm@jichi.ac.jp.
Pediatric research
|October 16, 2025
概括
川崎病 (KD) 患者血小板数量较低与抗静脉注射免疫球蛋白 (IVIG) 治疗和冠状动脉连续症有关,特别是在抗IVIG病例中. 早期血小板评估可以识别高风险的KD患者.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 川崎病 (KD) 是一种影响冠状动脉的儿科疾病.
- 血小板计数与静脉注射免疫球蛋白 (IVIG) 耐药性和冠状动脉 (CA) 在KD中的连续病变的关联是矛盾的.
- 以前的研究报告说,较低的血小板计数与IVIG耐药性有关,较高的计数与CA后续有关.
研究的目的:
- 解决关于川崎病血小板计数的相互矛盾的发现.
- 为了研究标准化血小板计数和IVIG抗性之间的关联.
- 评估IVIG抗性和IVIG响应性KD患者的血小板数量和CA序列之间的关系.
主要方法:
- 利用了一个大型的日本全国的KD数据库.
- 标准化血小板计数根据患者年龄和入院日.
- 采用多变量修改的波桑回归模型来分析血小板计数,IVIG抵抗和CA后续之间的关联.
主要成果:
- 在41,540名KD患者中,较低的标准化血小板计数与所有年龄组的IVIG耐药性相关,随着年龄的增长,这种关联得到了加强.
- 较低的标准化血小板计数与IVIG耐药患者的CA连续症有显著的相关性 (RR 1.12 [1.02-1.23]).
- 在IVIG反应的患者中,较低的血小板数量和CA连续症之间没有发现显著的关联 (RR 0.95 [0.86-1.04]).
结论:
- 较低的血小板计数独立地与IVIG耐药性和IVIG耐药的川崎病患者的CA后续相关.
- 这些发现通过考虑年龄,IVIG反应能力和血小板评估的时间来澄清之前的相互矛盾的结果.
- 早期评估KD患者的血小板计数可能有助于识别那些治疗失败和心脏并发症风险较高的人.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Structure and Function of Platelets
2.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.9K
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426


